NDC 70771-1325

candesartan cilexetil and hydrochlorothiazide

Candesartan Cilexetil And Hydrochlorothiazide

candesartan cilexetil and hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Candesartan Cilexetil; Hydrochlorothiazide.

Product ID70771-1325_180cdbf3-0f41-4372-af17-5ca2f902edc0
NDC70771-1325
Product TypeHuman Prescription Drug
Proprietary Namecandesartan cilexetil and hydrochlorothiazide
Generic NameCandesartan Cilexetil And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-04-14
Marketing CategoryANDA / ANDA
Application NumberANDA203466
Labeler NameCadila Healthcare Limited
Substance NameCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Active Ingredient Strength16 mg/1; mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70771-1325-0

1000 TABLET in 1 BOTTLE (70771-1325-0)
Marketing Start Date2018-04-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1325-3 [70771132503]

candesartan cilexetil and hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA203466
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-14

NDC 70771-1325-9 [70771132509]

candesartan cilexetil and hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA203466
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-14

NDC 70771-1325-1 [70771132501]

candesartan cilexetil and hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA203466
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-14

NDC 70771-1325-4 [70771132504]

candesartan cilexetil and hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA203466
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-14

NDC 70771-1325-0 [70771132500]

candesartan cilexetil and hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA203466
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-14

NDC 70771-1325-2 [70771132502]

candesartan cilexetil and hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA203466
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-14

Drug Details

Active Ingredients

IngredientStrength
CANDESARTAN CILEXETIL16 mg/1

OpenFDA Data

SPL SET ID:cb328bc1-5738-4620-b2b3-442e98388a86
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 578330
  • 578325
  • 802749

    • Pharmacological Class

    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "candesartan cilexetil and hydrochlorothiazide" or generic name "Candesartan Cilexetil And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0378-3001Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    0378-3002Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    0378-3003Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    33342-131Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    33342-132Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    33342-133Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    43547-459candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    43547-460candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    43547-461candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    62559-660Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    62559-661Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    62559-662Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    68382-194candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    68382-416candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    68382-195candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70771-1326candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70771-1325candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70771-1327candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70518-2720Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    0186-0162ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
    0186-0322ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
    62559-650ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    62559-651ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    62559-652ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.